These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 22740189)
1. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers. Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189 [TBL] [Abstract][Full Text] [Related]
2. Mefloquine for preventing malaria during travel to endemic areas. Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100 [TBL] [Abstract][Full Text] [Related]
4. Malaria chemoprophylaxis regimens: a descriptive drug utilization study. Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849 [TBL] [Abstract][Full Text] [Related]
5. Drugs for preventing malaria in travellers. Jacquerioz FA; Croft AM Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371 [TBL] [Abstract][Full Text] [Related]
6. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan. Hitani A; Nakamura T; Ohtomo H; Nawa Y; Kimura M J Infect Chemother; 2006 Oct; 12(5):277-82. PubMed ID: 17109092 [TBL] [Abstract][Full Text] [Related]
8. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision. Senn N; D'Acremont V; Landry P; Genton B Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513 [TBL] [Abstract][Full Text] [Related]
9. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries. Overbosch D J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756 [TBL] [Abstract][Full Text] [Related]
10. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population. Matsumura T; Fujii T; Miura T; Koibuchi T; Endo T; Nakamura H; Odawara T; Iwamoto A; Nakamura T J Infect Chemother; 2005 Aug; 11(4):196-8. PubMed ID: 16133712 [TBL] [Abstract][Full Text] [Related]
11. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected]. van Genderen PJ; Koene HR; Spong K; Overbosch D J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478 [TBL] [Abstract][Full Text] [Related]
12. Adherence to malaria prophylaxis among Peace Corps Volunteers in the Africa region, 2013. Landman KZ; Tan KR; Arguin PM Travel Med Infect Dis; 2015; 13(1):61-8. PubMed ID: 25534297 [TBL] [Abstract][Full Text] [Related]
13. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
14. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers. Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic use of antimalarials during pregnancy. Irvine MH; Einarson A; Bozzo P Can Fam Physician; 2011 Nov; 57(11):1279-81. PubMed ID: 22084457 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. Nakato H; Vivancos R; Hunter PR J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T; Bar-Meir M; Eisenberg N; Schwartz E J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. Kofoed K; Petersen E J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688 [TBL] [Abstract][Full Text] [Related]
19. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006. Andersson H; Askling HH; Falck B; Rombo L Mil Med; 2008 Dec; 173(12):1194-8. PubMed ID: 19149338 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]